| Certificates/Standards: | N; |
| Monthly Output: | Not provided |
| Regional: | New Zealand |
| Packaging Information: | Not provided |
| Mode Of Payment: | Not provided |
| Delivery Lead Time: | Not provided |
| Main Sales Markets: | North America,Western Europe,Eastern Europe,Australasia,Asia |
| Sample Provided: | Yes |
| Sample Policy: | Not provided |
| Minimum Quantity: | Not provided |
BLIS M18™ is specific strain of Streptococcus salivarius, a beneficial species native to the oral microbiota.
BLIS M18™ was initially identified for its exceptional ability to inhibit Streptococcus mutans, the primary bacterium responsible for dental caries.
With its targeted support for both teeth and gum health, BLIS M18™ is an essential ingredient in maintaining a healthy, resilient oral microbiome.